Autonomous DNA Nanobots for Molecular Diagnostics and Therapeutics


OPTIMuS™ is an autonomous DNA nanobot designed to detect multiple biomarkers in a field-deployable context. This paper describes the nanosystem. Patent Pending.


CamoNano™ is a biostable DNA nanobot designed to cure genetic disease. Patent Pending.

What we do

Nanodyne focuses exclusively on the use of DNA nanodesives ("nanobots") to improve human health. Nanodyne is a spin-out from Creodyne, llc, a Technology Incubator Company.

The ability to fold DNA into virtually any shape was described in 2006 by Dr. Paul Rothemund. Using the genetic code as an "engineering code" Dr. Rothemund showed that it was possible to program DNA fragments to self-assemble into virtually any two-dimensional or three-dimensional shape. Since that time there has been an explosion of interest, techniques, and tools for creating DNA nanostructures.

Nanodyne's two flagship projects are OPTIMuS™ and CamoNano™.

OPTIMuS™ is a self-assembling DNA nanosystem (hereafter "nanobot") designed to detect single or multiple biomarkers related to disease and infection. The vision for OPTIMuS™ is a robust field deployable nanobiosensor with a cell phone reader for point of care detection, analysis, and instant global telecommunication. The molecular diagnostics industry is projected to exceed 10B by 2023.

CamoNano™ is a new project focused on curing genetic disease. This project is in the early stages of development and represents an industry valued at 5.54B by 2021.

Contact Nanodyne

Nanodyne is actively seeking investors, partners, joint ventures, and collaborators to rapidly bring its vision for diagnostic and therapeutic DNA nanobots to fruition. If we have stimulated your interest please contact us at your convenience. We look forward to working with you!

  • Address

    2410 NE 13th Ct
    Ankeny, Iowa 50021
  • Email
  • Phone

    (515) 450-3960